This is consistent with studies of ACPA+ at-risk RA cohorts that have identified the presence of tenosynovitis as a predictor of progression to RA [20–22] and an imaging biomarker in early RA that is associated with poor clinical [23] and radiographic outcomes [10, 21]. Here, PRTN3 is linked to rheumatoid arthritis.